AMN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66533453693773E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.60982338570648E-14 |
Normal-vs-Stage2 |
7.28769999902568E-08 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
1.890020E-01 |
Stage1-vs-Stage3 |
2.538400E-02 |
Stage1-vs-Stage4 |
4.250300E-02 |
Stage2-vs-Stage3 |
1.352260E-02 |
Stage2-vs-Stage4 |
1.435960E-02 |
Stage3-vs-Stage4 |
9.476600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.88737914186277E-15 |
Normal-vs-AfricanAmerican |
2.2323254356138E-12 |
Normal-vs-Asian |
2.48259968138598E-10 |
Caucasian-vs-AfricanAmerican |
7.258600E-01 |
Caucasian-vs-Asian |
6.248000E-02 |
AfricanAmerican-vs-Asian |
5.519900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62592161956354E-12 |
Normal-vs-Female |
1.63025148935958E-12 |
Male-vs-Female |
6.728200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.83431048128568E-12 |
Normal-vs-Age(41-60Yrs) |
1.52100554373646E-14 |
Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
Normal-vs-Age(81-100Yrs) |
3.34950001068535E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.464200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.451200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.472800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.123800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.577200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.228200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.80077999999417E-05 |
Normal-vs-Grade 2 |
5.55111512312578E-16 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
8.849200E-01 |
Grade 1-vs-Grade 3 |
9.524600E-03 |
Grade 1-vs-Grade 4 |
1.864200E-02 |
Grade 2-vs-Grade 3 |
1.10009999998439E-07 |
Grade 2-vs-Grade 4 |
1.76002999999758E-05 |
Grade 3-vs-Grade 4 |
4.159600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63813407283442E-12 |
Normal-vs-ccB subtype |
1.64757096854373E-12 |
ccA subtype-vs-ccB subtype |
9.281400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63469238145808E-12 |
Normal-vs-N1 |
9.24689991244065E-10 |
N0-vs-N1 |
4.311700E-02 |
|
|